{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T18:54:06Z","timestamp":1787943246174,"version":"build-2784847793"},"reference-count":66,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To critically evaluate the existing evidence base surrounding the efficacy of preoperative 5\u2010alpha reductase inhibitor (5ARI) administration in the reduction of perioperative complication rates in transurethral resection of prostate (TURP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In April 2025, a systematic search of on\u2010line databases was conducted to identify randomised controlled trials (RCTs) that compared surgical outcomes and complication rates in patients undergoing TURP for benign prostatic hyperplasia (BPH) who were treated preoperatively with 5ARI (finasteride or dutasteride) as compared to placebo\/none. The efficacy of preoperative finasteride was evaluated through outcomes related to blood loss, rate of blood transfusion, and operative time. The physiological mechanism of 5ARI treatment was evaluated through microvessel density (MVD) and vascular endothelial growth factor (VEGF) expression of the resected specimen.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 30 RCTs met the inclusion criteria for this meta\u2010analysis in which a total of 2974 patients underwent TURP for BPH (1464 5ARI: 1410 Control). Intraoperative blood loss was significantly lower among 5ARI\u2010treated patients (\n                      <jats:italic>Z<\/jats:italic>\n                      \u2009=\u20096.37, mean difference [MD]\u2009=\u2009\u221282.58\u2009mL, 95% confidence interval [CI] \u2212107.98 to \u221257.18;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), which was reflected in a significantly lesser haemoglobin drop on the first postoperative day (\n                      <jats:italic>Z<\/jats:italic>\n                      \u2009=\u20096.84, MD\u2009=\u2009\u22120.90\u2009g\/dL, 95% CI\u22121.16 to \u22120.64;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). The MVD was significantly lower in resected specimens from 5ARI\u2010treated patients (MD\u2009=\u2009\u22126.18\u2009vessels\/mm\n                      <jats:sup>3<\/jats:sup>\n                      ,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), whilst expressing significantly less VEGF (MD\u2009=\u2009\u22123.25,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Patients treated with 5ARI required blood transfusion less frequently than controls (odds ratio 0.31,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). The use of 5ARI was associated with shorter operative time (MD\u2009=\u2009\u22123.47\u2009min,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.02) and lower volume of irrigation agents (MD\u2009=\u2009\u20132.07\u2009L,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Preoperative administration of 5ARIs significantly reduces intraoperative blood loss and risk of requiring blood transfusion in patients undergoing TURP for BPH. Even short durations (2\u2009weeks) of 5ARI therapy can significantly reduce prostate vascularity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/bju.70117","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:49:28Z","timestamp":1767854968000},"page":"430-443","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The role of 5\u2010alpha reductase inhibitors in transurethral resection of the prostate: a meta\u2010analysis of randomised controlled trials"],"prefix":"10.1111","volume":"137","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8437-1447","authenticated-orcid":false,"given":"Cian M.","family":"Hehir","sequence":"first","affiliation":[{"name":"Department of Surgery Royal College of Surgeons  Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin G.","family":"Calpin","sequence":"additional","affiliation":[{"name":"Department of Surgery Royal College of Surgeons  Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orla","family":"Cullivan","sequence":"additional","affiliation":[{"name":"Department of Surgery Royal College of Surgeons  Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon R.","family":"Daly","sequence":"additional","affiliation":[{"name":"Department of Surgery Royal College of Surgeons  Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin P.","family":"Dowling","sequence":"additional","affiliation":[{"name":"Department of Surgery Royal College of Surgeons  Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5298-1475","authenticated-orcid":false,"given":"Niall F.","family":"Davis","sequence":"additional","affiliation":[{"name":"Department of Urology Beaumont Hospital  Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/ijir.2008.55"},{"issue":"9","key":"e_1_2_9_3_1","first-page":"S3","article-title":"Benign prostatic hyperplasia: an overview","volume":"7","author":"Roehrborn CG","year":"2005","journal-title":"Rev Urol"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06628-8"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2017-00718"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2023.02.028"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.15653"},{"issue":"2","key":"e_1_2_9_8_1","first-page":"6","article-title":"HoLEP: the new gold standard for surgical treatment of benign prostatic hyperplasia","volume":"28","author":"Shvero A","year":"2021","journal-title":"Can J Urol"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2009.09052.x"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11934-022-01091-z"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/bjaceaccp\/mkp012"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2005.12.042"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/2090598X.2022.2026011"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2024.05.015"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.24616"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2006.06619.x"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/00365590510007694"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11918-008-0019-x"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2005.05849.x"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.12917"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2003.09.012"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-009-0493-y"},{"key":"e_1_2_9_23_1","first-page":"213","article-title":"The effect of two weeks preoperative finasteride therapy in reducing prostate vascularity","volume":"26","author":"Khwaja MA","year":"2016","journal-title":"J Coll Physicians Surg Pak"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.4103\/UA.UA_35_20"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-015-0043-4"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajur.2021.05.011"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1159\/000453669"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-5-13"},{"key":"e_1_2_9_30_1","first-page":"108","article-title":"A note on standard deviation and standard error","volume":"29","author":"Hassani H","year":"2010","journal-title":"Teach Math Appl"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.16864"},{"key":"e_1_2_9_32_1","unstructured":"Training C.Review manager (RevMan) computer program. Version 5.4. The Cochrane Collaboration [cited 3 July 2024] 2020"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2008.08.461"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365590903164498"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1089\/end.2012.0231"},{"key":"e_1_2_9_37_1","first-page":"1","article-title":"Efficacy of combination dutasteride and lycopene to reduce bleeding in benign prostate hyperplasia (BPH) post\u2010transurethral resection of the prostate (TURP) overview of hypoxia inducible factor\u20101 alpha (HIF\u20101 \u03b1) expression and hematocrit levels","volume":"25","author":"Nugroho EA","year":"2015","journal-title":"Maj Obat Tradis"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1089\/end.2016.0696"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.18203\/2320-6012.ijrms20183248"},{"key":"e_1_2_9_40_1","first-page":"157","article-title":"Effect of preoperative dutasteride on bleeding related to transurethral resection of prostate in patients with benign prostatic hyperplasia","volume":"7","author":"Rahman MM","year":"2019","journal-title":"J Biosci Med"},{"key":"e_1_2_9_41_1","first-page":"1047","article-title":"Effect of dutasteride in decreasing surgical blood loss following unipolar transurethral resection of prostate in patients with benign prostatic hyperplasia: a quasi experimental study","volume":"69","author":"Khoso MA","year":"2019","journal-title":"Pak Armed Forces Med"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/CU9.0000000000000226"},{"key":"e_1_2_9_43_1","article-title":"Comparison of intraoperative blood loss in monopolar transurethral resection of the prostate with and without two weeks of preoperative dutasteride","volume":"17","author":"Ali AS","year":"2025","journal-title":"Cureus"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.pcan.4500818"},{"key":"e_1_2_9_45_1","first-page":"2562","article-title":"Effect of preoperative finasteride on the volume or length density of prostate vessels, intraoperative, postoperative blood loss during and after monopolar transurethral resection of prostate: a dose escalation randomized clinical trial using stereology methods","volume":"13","author":"Aminsharifi A","year":"2016","journal-title":"Urol J"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.afju.2018.05.005"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.5958\/0976-5506.2019.00872.6"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12301-021-00211-4"},{"key":"e_1_2_9_49_1","first-page":"235","volume":"13","author":"Allahyani H","year":"2024","journal-title":"Int J Life Sci Biotechnol Pharma Res"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(01)01408-X"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)64287-5"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1159\/000082709"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1080\/003655902320131848"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.4314\/tjpr.v16i12.25"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.33545\/surgery.2020.v4.i1d.339"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-167643"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2490-14-67"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001379"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2020.3385"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-32356-3"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2013.742885"},{"key":"e_1_2_9_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2010.02157.x"},{"key":"e_1_2_9_63_1","first-page":"535","article-title":"Finasteride in the treatment of patients with benign prostatic hyperplasia: a review","volume":"5","author":"Smith AB","year":"2009","journal-title":"Ther Clin Risk Manag"},{"issue":"9","key":"e_1_2_9_64_1","first-page":"S31","article-title":"Comparison of clinical trials with finasteride and dutasteride","volume":"6","author":"Nickel JC","year":"2004","journal-title":"Rev Urol"},{"key":"e_1_2_9_65_1","doi-asserted-by":"publisher","DOI":"10.4111\/kju.2010.51.10.704"},{"key":"e_1_2_9_66_1","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000326"},{"key":"e_1_2_9_67_1","doi-asserted-by":"publisher","DOI":"10.1089\/end.2010.0174"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bju.70117","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bju.70117","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bju.70117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T11:58:09Z","timestamp":1773316689000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/bju.70117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1111\/bju.70117"],"URL":"https:\/\/doi.org\/10.1111\/bju.70117","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"value":"1464-4096","type":"print"},{"value":"1464-410X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"2026-01-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}